Evidence map›Paper›PMID 21766162›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2012

Palliative sedation at the end of life at a tertiary cancer center.

Augusto Caraceni, Ernesto Zecca, Cinzia Martini, Giovanna Gorni, Tiziana Campa, Cinzia Brunelli, Franco De Conno

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Palliative pharmacological sedation for terminally ill adults.The Cochrane database of systematic reviews · 2015
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Palliative sedation in advanced cancer patients hospitalized in a specialized palliative care unit.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. In-service documentation tools and statements on palliative sedation in Germany--do they meet the EAPC framework recommendations? A qualitative document analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  17. The EAPC framework on palliative sedation and clinical practice--a questionnaire-based survey in Germany.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2014
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Augusto CaraceniPalliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS-Istituto Nazionale dei Tumori-Milano, Via Venezian 1, 20133, Milan, Italy.
Ernesto Zecca
Cinzia Martini
Giovanna Gorni
Tiziana Campa
Cinzia Brunelli
Franco De Conno
Fondazione IRCCS Istituto Nazionale dei Tumori · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to describe the use of palliative sedation (PS) its indications and outcomes in patients followed up till death by an inpatient palliative care consult team (PCCT) at a tertiary cancer center.

methodsAll patients referred for 5 years to the PCCT and followed up till death were eligible for the study. Both PCCT recordings and hospital charts were reviewed and a codified assessment was performed.

resultsOver a total of 2,033 consecutive consults, 129 patients died during admission and were eligible. Eighty-three had the indication to PS, 4% of all consults (95% confidence interval [95%CI], 3% to 5%) and 64% of eligible patients (95%CI, 56% to 73%). PS was more frequently indicated in males and in patients with recurrent dyspnea and recurrent agitation, while it was less frequently indicated in older people and in patients with cerebral metastases and recurrent drowsiness. The most frequent indications to PS were dyspnea (37%) and delirium (31%) alone or combined with other symptoms. PS was successfully achieved in 69 patients; the drugs most frequently used for PS were midazolam (46%), haloperidol (35%), and chlorpromazine (32%) and opioid dose escalation was higher in sedated patients (P < 0.01).

conclusionsPS is an important intervention in the management of terminal disease by a consulting palliative care team. Improved collaboration and communication between the hospital staff and the PCCT should be offered to meet patients' needs when PS is required.

Indexed as

AgedAge FactorsCancer Care FacilitiesDose-Response Relationship, DrugFemaleFollow-Up StudiesHumansHypnotics and SedativesMaleMiddle AgedNeoplasmsPalliative CarePatient Care TeamReferral and ConsultationRetrospective StudiesSex FactorsHypnotics and Sedatives

Identifiers

PMID21766162
OpenAlexW2080250354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.